Repositioning of Anti-Parasitic Drugs in Cyclodextrin Inclusion Complexes for Treatment of Triple-Negative Breast Cancer

AAPS PharmSciTech - Switzerland
doi 10.1208/s12249-018-1169-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Non-Platinum Metal Complexes as Potential Anti-Triple Negative Breast Cancer Agents

Crystals
Materials ScienceInorganic ChemistryChemical EngineeringCondensed Matter Physics
2018English

Targeting MYC for Triple-Negative Breast Cancer Treatment

Oncoscience
Cancer ResearchOncology
2018English

Cetuximab-Conjugates Nanoparticles for the Treatment of Triple Negative Breast Cancer

2019English

Triple-Negative Breast Cancer

2018English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

Role of Immunotherapy in Triple-Negative Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2020English

A Review of Triple-Negative Breast Cancer

Cancer Control
MedicineOncologyHematology
2010English

Cholecalciferol-Peg Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer

AAPS PharmSciTech
EvolutionEcologySystematicsCrop ScienceAquatic ScienceBehaviorPharmaceutical ScienceMedicineAgronomyDrug Discovery
2017English

Platinum-Based Therapy for Triple-Negative Breast Cancer Treatment: A Meta-Analysis

Molecular and Clinical Oncology
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy